TMEM72 Inhibits the proliferation by promoting cellular senescence through the activation of the P38/MAPK signaling pathway in renal cell carcinoma
Fang Dai, Huming Wang, Wenhao Chu, Yu Lin, Jinqing He, Hantao Wen, Xiaotong Feng, Xudong Liu, Zihan Xu, Liangkuan Bi, Zhaojie Lyu · 2026
Read TMEM72 Inhibits the proliferation by promoting cellular senescence through the activation of the P38/MAPK signaling pathway in renal cell carcinoma by Fang Dai, Huming Wang, Wenhao Chu, Yu Lin, Jinqing He, Hantao Wen, Xiaotong Feng, Xudong Liu, Zihan Xu, Liangkuan Bi, Zhaojie Lyu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13147424.txt.
Description
Kidney cancer lacks reliable markers for predicting which patients will fare poorly. Fang Dai and co-authors focus on TMEM72, a protein enriched in kidney tissue that is reduced in renal cell carcinoma. Protein profiling of tumor and nearby tissue flagged it, and large cohort data tied low levels to worse prognosis.
In lab models, raising TMEM72 slowed cancer cell growth and tumor formation in mice, while silencing it sped growth. The protein pushed cells into senescence, a permanent stop state, by switching on the p38 MAPK pathway and raising activity of the guard protein p53. Blocking p38 partly undid the effect. The authors propose TMEM72 both as a prognostic marker and as a possible therapeutic lever.
Catalog record
| CREATOR | Fang Dai, Huming Wang, Wenhao Chu, Yu Lin, Jinqing He, Hantao Wen, Xiaotong Feng, Xudong Liu, Zihan Xu, Liangkuan Bi, Zhaojie Lyu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |